Related Experiment Videos

[Variants of left ventricular hypertrophy in patients on programmed hemodialysis]

Klinicheskaia Meditsina
|December 11, 2002
PubMed

Insights

Programmed hemodialysis (PHD) effectively treated chronic renal failure (CRF) in most patients. However, left ventricular hypertrophy progression during dialysis indicates a poor prognosis, particularly in older individuals.

Area of Science:

  • Nephrology
  • Cardiology
  • Medical Technology

Context:

  • Programmed hemodialysis (PHD) is a treatment for chronic renal failure (CRF).
  • Cardiovascular complications are a major concern in CRF patients undergoing dialysis.
  • Left ventricular hypertrophy (LVH) is a known cardiac adaptation in CRF.

Purpose:

  • To identify objective prognostic indicators for cardiovascular function in CRF patients undergoing PHD.
  • To compare the development of LVH in younger versus elderly CRF patients on PHD.
  • To assess the impact of dialysis duration on LVH progression and prognosis.

Summary:

  • PHD was successfully applied to 189 of 207 CRF patients over 10 years.
  • LVH development was studied in young (18-40 years) and elderly (55-73 years) patient groups.
  • Concentric LVH transitioned to eccentric or mixed forms with increased 'dialysis age', indicating a worse prognosis, especially in elderly patients.

Impact:

  • The study highlights the prognostic significance of LVH progression in PHD patients.
  • Findings suggest closer cardiovascular monitoring for CRF patients, particularly the elderly, undergoing long-term dialysis.
  • Identifying unfavorable prognostic trends like LVH progression can help prevent fatal complications in CRF management.

Related Concept Videos